Bilal Aijaz MD FACC, FSCAI RPVI
Interventional Cardiology
Director of Vascular Medicine and Intervention Director Vascular Laboratory Rocky Mountain Regional VA Medical Center Assistant Professor of Medicine, University of Colorado School of Medicine
Join to View Full Profile
1700 Wheeling StAurora, CO 80045
Phone+1 720-848-0000
Dr. Aijaz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
St Elizabeths Medical Center-Tufts University Endovascular & Structural Heart Disease, Cardiovascular Disease, 2021 - 2022
Beth Israel Deaconess Medical CenterFellowship, Interventional Cardiology, 2012 - 2013
University of Alabama Medical CenterFellowship, Cardiovascular Disease, 2009 - 2012
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2006 - 2009
Aga Khan Medical CollegeClass of 2004
Certifications & Licensure
AL State Medical License 2009 - Present
UT State Medical License 2013 - 2026
CO State Medical License 2022 - 2025
MA State Medical License 2011 - 2023
MN State Medical License 2008 - 2012
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- Outcomes After Noncardiac Surgery Performed Within 2 Years of Percutaneous Coronary Intervention.Neel M Butala, Annika Hebbe, Binita Shah, Nathaniel R Smilowitz, Bilal Aijaz
Journal of the American Heart Association. 2025-03-18 - Long-Term Use of Beta-Blockers After Myocardial Infarction in the United States.Neel M Butala, Stephen W Waldo, Dhaval Kolte, P Michael Ho, Bilal Aijaz
JACC. Advances. 2025-03-18 - Temporal trends and hospital variation in the use of P2Y12 inhibitors among patients undergoing percutaneous coronary intervention: Insights from the VA CART program.Bilal Aijaz, Thomas J Glorioso, Neel Butala, Stephen W Waldo
Catheterization and Cardiovascular Interventions. 2023-09-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
